Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride

Clinical trial NCT00981162 · COMPLETED

Trial details

NCT number: NCT00981162
Sponsor: Roswell Park Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acinar Cell Adenocarcinoma of the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2009-08-01
Primary completion: 2011-08-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.